Corcept director James N. Wilson disposes of $1.11 million in common shares

PUBT · 1d ago
Corcept director James N. Wilson disposes of $1.11 million in common shares
  • Corcept director James N. Wilson reported selling 10,000 common shares on Sept. 15, 2026.
  • Sales prices ranged from USD 110.27 to USD 111.7 per share.
  • Holdings via the James N. Wilson and Pamela D. Wilson Trust fell to 1,064,543 shares.
  • Separate indirect holdings remained 200,000 shares in each of two 2025 grantor retained annuity trusts.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-393124), on September 16, 2026, and is solely responsible for the information contained therein.